The Interplay of PD-L1, Kynurenine Pathway, and Vitamin D Shapes an Immunosuppressive Microenvironment in Acute Myeloid Leukemia
Three factors converging in AML patients—immune checkpoint signaling, tryptophan metabolism, and vitamin D—reveal how cancers evade immunity.
This study of 127 AML patients reveals an immunosuppressive network where PD-L1 expression, tryptophan metabolism via the kynurenine pathway, and vitamin D deficiency converge to promote immune evasion. Low vitamin D was associated with 2.7-fold higher odds of activated Tregs.
What the study was
- Study design
- Prospective observational
- Population
- Newly diagnosed AML patients
- Sample size
- 127
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Asian Pacific Journal of Cancer Prevention
Why it surfaced
Adds to understanding of AML immune microenvironment; potential therapeutic implications for combination immunotherapy.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.